Univar Solutions Inc. announced the Company has reached an agreement with W. R. Grace & Co. to distribute Grace's SYLOID® FP silica for pharmaceutical and nutraceutical markets in the majority of European countries*. The agreement builds upon the existing global relationship between Univar Solutions and Grace in the United States, Brazil, Mexico, and the majority of Europe providing customers access to this multifunctional excipient used in over the counter and prescription drug delivery solutions and supplements.

Grace SYLOID® FP silica contributes efficiency and performance in many pharmaceutical and nutraceutical applications, helping to address powder flow and caking challenges. SYLOID® FP silica is engineered hydrated silicon dioxide produced under controlled conditions, meeting USP/NF, EMA, JP, and ANVISA requirements and offering high chemical purity and performance. SYLOID® FP silica is easy to incorporate, offering optimal performance as a glidant, carrier for active ingredients, tableting aid, thickener and disintegrant, which helps improve the handling, adsorption, and dissolution of many pharmaceuticals and nutraceuticals.

The excipient's unique design combines adsorption capacity, particle size, density, and internal surface area to provide multifunctional benefits or optimize an application. This helps minimize the number of excipients used and the complexity of formulations while expediting manufacturing, ultimately improving the efficacy of the final dosage form.